Cargando…

Efficacy of Short Hydration for Intermediate to High-Dose Cisplatin-Based Chemotherapy for Outpatients: SHORTCIS Trial

OBJECTIVE: Supporting data exists concerning short hydration to prevent cisplatin-induced nephrotoxicity. However, only a few studies exist. Further, data remains limited, comprising mostly retrospective data. Therefore, the study would like to evaluate the efficacy of short hydration using a prospe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chantharakhit, Chaichana, Sujaritvanichpong, Nantapa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924323/ https://www.ncbi.nlm.nih.gov/pubmed/36308355 http://dx.doi.org/10.31557/APJCP.2022.23.10.3323

Ejemplares similares

Prognostic Impact of the Advanced Lung Cancer Inflammation Index (ALI) in Metastatic Non-Small Cell Lung Cancer Treated with First Line Chemotherapy
por: Chantharakhit, Chaichana, et al.
Publicado: (2021)

Prognostic Scoring System Development for Malignant Spinal Cord Compression
por: Chantharakhit, Chaichana, et al.
Publicado: (2022)

Developing a Prediction Score for the Diagnosis of Malignant Pleural Effusion: MPE Score
por: Chantharakhit, Chaichana, et al.
Publicado: (2022)

Prognostic Value of the Pre-Treatment Prognostic Nutritional Index for Patients with Unresectable Locally-Advanced and Advanced Stage Upper Gastrointestinal Tract Cancer
por: Chantharakhit, Chaichana, et al.
Publicado: (2022)

Efficacy of Premedication Protocol without Ranitidine for Taxane Regimen: A Multicenter Non-Randomized Historical Controlled Study
por: Chantharakhit, Chaichana, et al.
Publicado: (2022)

Comparison of Short and Continuous Hydration Regimen in Chemotherapy Containing Intermediate- to High-Dose Cisplatin
por: Ouchi, Akira, et al.
Publicado: (2014)

Feasibility study of short hydration using oral rehydration solution in cisplatin including chemotherapy of lung cancer
por: Sato, Junya, et al.
Publicado: (2016)

The effect of mannitol addition to hydration on acute kidney injury event after high dose cisplatin chemotherapy: an ambispective cohort study
por: Rachman, Andhika, et al.
Publicado: (2022)

Reduction in nephrotoxicities using short hydration for chemotherapy containing cisplatin: a consecutive analysis of 467 patients with thoracic malignancies
por: Tanaka, Midori, et al.
Publicado: (2018)

Furosemide versus mannitol in Japanese patients with thoracic malignancy who received cisplatin-based chemotherapy using short hydration: study protocol for a randomised controlled trial
por: Murakami, Eriko, et al.
Publicado: (2019)

Effect of Short Hydration on Cisplatin-Induced Nephrotoxicity in Cancer Patients: A Retrospective Study
por: Ashrafi, Farzaneh, et al.
Publicado: (2017)

Risk factor analysis for cisplatin-induced nephrotoxicity with the short hydration method in diabetic patients
por: Saito, Yoshitaka, et al.
Publicado: (2023)

Reducing Time to Discharge after Chemotherapy by Standardizing Workflow and Providing Outpatient Intravenous Hydration
por: Sitthi-Amorn, Jitsuda, et al.
Publicado: (2021)

Phase II study of adjuvant chemotherapy with pemetrexed and cisplatin with a short hydration method for completely resected nonsquamous non‐small cell lung cancer
por: Tachihara, Motoko, et al.
Publicado: (2020)

Hydration and Secondary Ozonide of the Criegee Intermediate of Sabinene
por: Almatarneh, Mansour H., et al.
Publicado: (2018)

Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours
por: Anthoney, D A, et al.
Publicado: (2004)

Hydration with Mannitol and Dextrose May Promote Cisplatin-Induced Nephrotoxicity: Test of Five Protocols of Hydration during Cisplatin Therapy in Rat Models
por: Khosravi, Mohammad-Sedigh, et al.
Publicado: (2021)

Postoperative chemoradiation therapy using high dose cisplatin and fluorouracil for high- and intermediate-risk uterine cervical cancer
por: Miyauchi, Rise, et al.
Publicado: (2017)

Diabetes mellitus degenerates cisplatin-induced nephrotoxicity in short hydration method: a propensity score-matching analysis
por: Saito, Yoshitaka, et al.
Publicado: (2022)

Dose finding study of granisetron in patients receiving high-dose cisplatin chemotherapy. The Granisetron Study Group.
por: Riviere, A.
Publicado: (1994)

Nucleation and Crystallization of Ferrous Phosphate Hydrate via an Amorphous Intermediate
por: Paskin, Alice, et al.
Publicado: (2023)

Magnesium supplementation and high volume hydration reduce the renal toxicity caused by cisplatin-based chemotherapy in patients with lung cancer: a toxicity study
por: Oka, Takako, et al.
Publicado: (2014)

Efficacy and safety of vinorelbine and cisplatin regimen of different doses and intensities for neoadjuvant chemotherapy in patients with locally advanced esophageal carcinoma
por: Jin, Ke, et al.
Publicado: (2021)

Large Doses of Chloral Hydrate
Publicado: (1873)

Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
por: Saito, H., et al.
Publicado: (2013)

Comparison of the Efficacy between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer
por: Lee, Jieun, et al.
Publicado: (2015)

A Dose-Finding Trial for Hyperthermic Intraperitoneal Cisplatin in Gynecological Cancer Patients Receiving Hyperthermic Intraperitoneal Chemotherapy
por: Chan, Chui-ying, et al.
Publicado: (2021)

A network meta-analysis of the short-term efficacy of five chemotherapy regimens based on cisplatin and fluorouracil for esophagogastric junctional adenocarcinoma
por: Wang, Cong, et al.
Publicado: (2017)

Investigating the Intermediate Water Feature of Hydrated Titanium Containing Bioactive Glass
por: Mabrouk, Mostafa, et al.
Publicado: (2021)

Impact of relative dose intensity in gemcitabine–cisplatin chemotherapy for metastatic urothelial carcinoma
por: Kohei, Naoki, et al.
Publicado: (2018)

High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting
por: Lisenko, Katharina, et al.
Publicado: (2017)

Intra-arterial induction high-dose chemotherapy with cisplatin for oral and oropharyngeal cancer: long-term results
por: Kovács, A F
Publicado: (2004)

A safe and effective dose of cisplatin in hepatic arterial infusion chemotherapy for hepatocellular carcinoma
por: Osaki, Akihiko, et al.
Publicado: (2013)

Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients receiving additional induction chemotherapy
por: Lv, Jia‐Wei, et al.
Publicado: (2018)

Hydration Efficacy of a Milk Permeate-Based Oral Hydration Solution
por: Berry, Craig W., et al.
Publicado: (2020)

Randomised trial for the prevention of delayed emesis in patients receiving high-dose cisplatin.
por: Matsui, K., et al.
Publicado: (1996)

Treatment outcomes of standard (high dose) cisplatin and non‐standard chemotherapy for locally advanced head and neck cancer
por: Alamgeer, Muhammad, et al.
Publicado: (2022)

Comparing high‐dose cisplatin with cisplatin‐based combination chemotherapy in definitive concurrent chemoradiation setting for locally advanced head and neck squamous cell carcinoma (LAHNSCC)
por: Furqan, Muhammad, et al.
Publicado: (2019)

Clinical efficacy of highly agglutinative staphylococcin combined with neoadjuvant chemotherapy on patients with intermediate or advanced oral cancer
por: Guo, Nan, et al.
Publicado: (2022)

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis
por: Nadiradze, Giorgi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_phvbmkgevv1u047sj6q52i6mdl